1 Study Coverage 1.1 Amebiasis Product Introduction 1.2 Global Amebiasis Outlook 2017 VS 2022 VS 2028 1.2.1 Global Amebiasis Sales in US$ Million for the Year 2017-2028 1.2.2 Global Amebiasis Sales in Volume for the Year 2017-2028 1.3 United States Amebiasis Outlook 2017 VS 2022 VS 2028 1.3.1 United States Amebiasis Sales in US$ Million for the Year 2017-2028 1.3.2 United States Amebiasis Sales in Volume for the Year 2017-2028 1.4 Amebiasis Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Amebiasis in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Amebiasis Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Amebiasis Market Dynamics 1.5.1 Amebiasis Industry Trends 1.5.2 Amebiasis Market Drivers 1.5.3 Amebiasis Market Challenges 1.5.4 Amebiasis Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Amebiasis Market Segment by Type 2.1.1 Metronidazole 2.1.2 Paromomycin 2.1.3 Tinidazole 2.1.4 Other 2.2 Global Amebiasis Market Size by Type 2.2.1 Global Amebiasis Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Amebiasis Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Amebiasis Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Amebiasis Market Size by Type 2.3.1 United States Amebiasis Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Amebiasis Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Amebiasis Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Amebiasis Market Segment by Application 3.1.1 Hospital 3.1.2 Pharmacy 3.2 Global Amebiasis Market Size by Application 3.2.1 Global Amebiasis Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Amebiasis Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Amebiasis Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Amebiasis Market Size by Application 3.3.1 United States Amebiasis Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Amebiasis Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Amebiasis Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Amebiasis Competitor Landscape by Company 4.1 Global Amebiasis Market Size by Company 4.1.1 Top Global Amebiasis Manufacturers Ranked by Revenue (2021) 4.1.2 Global Amebiasis Revenue by Manufacturer (2017-2022) 4.1.3 Global Amebiasis Sales by Manufacturer (2017-2022) 4.1.4 Global Amebiasis Price by Manufacturer (2017-2022) 4.2 Global Amebiasis Concentration Ratio (CR) 4.2.1 Amebiasis Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Amebiasis in 2021 4.2.3 Global Amebiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Amebiasis Manufacturing Base Distribution, Product Type 4.3.1 Global Amebiasis Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Amebiasis Product Type 4.3.3 Date of International Manufacturers Enter into Amebiasis Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Amebiasis Market Size by Company 4.5.1 Top Amebiasis Players in United States, Ranked by Revenue (2021) 4.5.2 United States Amebiasis Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Amebiasis Sales by Players (2020, 2021 & 2022) 5 Global Amebiasis Market Size by Region 5.1 Global Amebiasis Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Amebiasis Market Size in Volume by Region (2017-2028) 5.2.1 Global Amebiasis Sales in Volume by Region: 2017-2022 5.2.2 Global Amebiasis Sales in Volume Forecast by Region (2023-2028) 5.3 Global Amebiasis Market Size in Value by Region (2017-2028) 5.3.1 Global Amebiasis Sales in Value by Region: 2017-2022 5.3.2 Global Amebiasis Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Amebiasis Market Size YoY Growth 2017-2028 6.1.2 North America Amebiasis Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Amebiasis Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Amebiasis Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Amebiasis Market Size YoY Growth 2017-2028 6.3.2 Europe Amebiasis Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Amebiasis Market Size YoY Growth 2017-2028 6.4.2 Latin America Amebiasis Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Amebiasis Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Amebiasis Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Dr. Reddy’s Laboratories 7.1.1 Dr. Reddy’s Laboratories Corporation Information 7.1.2 Dr. Reddy’s Laboratories Description and Business Overview 7.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Dr. Reddy’s Laboratories Amebiasis Products Offered 7.1.5 Dr. Reddy’s Laboratories Recent Development 7.2 Mission Pharmacal 7.2.1 Mission Pharmacal Corporation Information 7.2.2 Mission Pharmacal Description and Business Overview 7.2.3 Mission Pharmacal Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Mission Pharmacal Amebiasis Products Offered 7.2.5 Mission Pharmacal Recent Development 7.3 Aceto Corporation 7.3.1 Aceto Corporation Corporation Information 7.3.2 Aceto Corporation Description and Business Overview 7.3.3 Aceto Corporation Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Aceto Corporation Amebiasis Products Offered 7.3.5 Aceto Corporation Recent Development 7.4 Mylan Pharmaceuticals 7.4.1 Mylan Pharmaceuticals Corporation Information 7.4.2 Mylan Pharmaceuticals Description and Business Overview 7.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Mylan Pharmaceuticals Amebiasis Products Offered 7.4.5 Mylan Pharmaceuticals Recent Development 7.5 Impax Laboratories 7.5.1 Impax Laboratories Corporation Information 7.5.2 Impax Laboratories Description and Business Overview 7.5.3 Impax Laboratories Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Impax Laboratories Amebiasis Products Offered 7.5.5 Impax Laboratories Recent Development 7.6 Pfizer 7.6.1 Pfizer Corporation Information 7.6.2 Pfizer Description and Business Overview 7.6.3 Pfizer Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Pfizer Amebiasis Products Offered 7.6.5 Pfizer Recent Development 7.7 Sanofi 7.7.1 Sanofi Corporation Information 7.7.2 Sanofi Description and Business Overview 7.7.3 Sanofi Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Sanofi Amebiasis Products Offered 7.7.5 Sanofi Recent Development 7.8 Lupin Pharmaceuticals 7.8.1 Lupin Pharmaceuticals Corporation Information 7.8.2 Lupin Pharmaceuticals Description and Business Overview 7.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Lupin Pharmaceuticals Amebiasis Products Offered 7.8.5 Lupin Pharmaceuticals Recent Development 7.9 Glenmark Pharmaceuticals 7.9.1 Glenmark Pharmaceuticals Corporation Information 7.9.2 Glenmark Pharmaceuticals Description and Business Overview 7.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Glenmark Pharmaceuticals Amebiasis Products Offered 7.9.5 Glenmark Pharmaceuticals Recent Development 7.10 Sun Pharmaceutical 7.10.1 Sun Pharmaceutical Corporation Information 7.10.2 Sun Pharmaceutical Description and Business Overview 7.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Sun Pharmaceutical Amebiasis Products Offered 7.10.5 Sun Pharmaceutical Recent Development 7.11 Heritage Pharmaceuticals 7.11.1 Heritage Pharmaceuticals Corporation Information 7.11.2 Heritage Pharmaceuticals Description and Business Overview 7.11.3 Heritage Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Heritage Pharmaceuticals Amebiasis Products Offered 7.11.5 Heritage Pharmaceuticals Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Amebiasis Industry Chain Analysis 8.2 Amebiasis Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Amebiasis Distributors 8.3 Amebiasis Production Mode & Process 8.4 Amebiasis Sales and Marketing 8.4.1 Amebiasis Sales Channels 8.4.2 Amebiasis Distributors 8.5 Amebiasis Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Amebiasis CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Amebiasis Market Trends Table 3. Amebiasis Market Drivers Table 4. Amebiasis Market Challenges Table 5. Amebiasis Market Restraints Table 6. Global Amebiasis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Amebiasis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Amebiasis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Amebiasis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Amebiasis Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Amebiasis Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Amebiasis Revenue Share by Manufacturer, 2017-2022 Table 13. Global Amebiasis Sales by Manufacturer, (K MT), 2017-2022 Table 14. Global Amebiasis Sales Share by Manufacturer, 2017-2022 Table 15. Global Amebiasis Price by Manufacturer (2017-2022) & (USD/MT) Table 16. Global Amebiasis Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Amebiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis as of 2021) Table 18. Top Players of Amebiasis in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Amebiasis Product Type Table 20. Date of International Manufacturers Enter into Amebiasis Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Amebiasis Players in United States Market, Ranking by Revenue (2021) Table 23. United States Amebiasis Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Amebiasis Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Amebiasis Sales by Players, (K MT), 2020, 2021 & 2022 Table 26. United States Amebiasis Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Amebiasis Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Amebiasis Sales in Volume by Region (2017-2022) & (K MT) Table 29. Global Amebiasis Sales in Volume Forecast by Region (2023-2028) & (K MT) Table 30. Global Amebiasis Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Amebiasis Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Amebiasis Sales in Volume by Country (2017-2028) & (K MT) Table 33. North America Amebiasis Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Amebiasis Sales in Volume by Region (2017-2028) & (K MT) Table 35. Asia Pacific Amebiasis Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Amebiasis Sales in Volume by Country (2017-2028) & (K MT) Table 37. Europe Amebiasis Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Amebiasis Sales in Volume by Country (2017-2028) & (K MT) Table 39. Latin Americaa Amebiasis Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Amebiasis Sales in Volume by Country (2017-2028) & (K MT) Table 41. Middle East and Africa Amebiasis Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Dr. Reddy’s Laboratories Corporation Information Table 43. Dr. Reddy’s Laboratories Description and Business Overview Table 44. Dr. Reddy’s Laboratories Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 45. Dr. Reddy’s Laboratories Amebiasis Product Table 46. Dr. Reddy’s Laboratories Recent Development Table 47. Mission Pharmacal Corporation Information Table 48. Mission Pharmacal Description and Business Overview Table 49. Mission Pharmacal Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 50. Mission Pharmacal Product Table 51. Mission Pharmacal Recent Development Table 52. Aceto Corporation Corporation Information Table 53. Aceto Corporation Description and Business Overview Table 54. Aceto Corporation Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 55. Aceto Corporation Product Table 56. Aceto Corporation Recent Development Table 57. Mylan Pharmaceuticals Corporation Information Table 58. Mylan Pharmaceuticals Description and Business Overview Table 59. Mylan Pharmaceuticals Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 60. Mylan Pharmaceuticals Product Table 61. Mylan Pharmaceuticals Recent Development Table 62. Impax Laboratories Corporation Information Table 63. Impax Laboratories Description and Business Overview Table 64. Impax Laboratories Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 65. Impax Laboratories Product Table 66. Impax Laboratories Recent Development Table 67. Pfizer Corporation Information Table 68. Pfizer Description and Business Overview Table 69. Pfizer Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 70. Pfizer Product Table 71. Pfizer Recent Development Table 72. Sanofi Corporation Information Table 73. Sanofi Description and Business Overview Table 74. Sanofi Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 75. Sanofi Product Table 76. Sanofi Recent Development Table 77. Lupin Pharmaceuticals Corporation Information Table 78. Lupin Pharmaceuticals Description and Business Overview Table 79. Lupin Pharmaceuticals Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 80. Lupin Pharmaceuticals Product Table 81. Lupin Pharmaceuticals Recent Development Table 82. Glenmark Pharmaceuticals Corporation Information Table 83. Glenmark Pharmaceuticals Description and Business Overview Table 84. Glenmark Pharmaceuticals Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 85. Glenmark Pharmaceuticals Product Table 86. Glenmark Pharmaceuticals Recent Development Table 87. Sun Pharmaceutical Corporation Information Table 88. Sun Pharmaceutical Description and Business Overview Table 89. Sun Pharmaceutical Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 90. Sun Pharmaceutical Product Table 91. Sun Pharmaceutical Recent Development Table 92. Heritage Pharmaceuticals Corporation Information Table 93. Heritage Pharmaceuticals Description and Business Overview Table 94. Heritage Pharmaceuticals Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 95. Heritage Pharmaceuticals Product Table 96. Heritage Pharmaceuticals Recent Development Table 97. Key Raw Materials Lists Table 98. Raw Materials Key Suppliers Lists Table 99. Amebiasis Customers List Table 100. Amebiasis Distributors List Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Amebiasis Product Picture Figure 2. Global Amebiasis Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Amebiasis Market Size 2017-2028 (US$ Million) Figure 4. Global Amebiasis Sales 2017-2028 (K MT) Figure 5. United States Amebiasis Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Amebiasis Market Size 2017-2028 (US$ Million) Figure 7. United States Amebiasis Sales 2017-2028 (K MT) Figure 8. United States Amebiasis Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Amebiasis Market Share in Global, in Volume (K MT) 2017-2028 Figure 10. Amebiasis Report Years Considered Figure 11. Product Picture of Metronidazole Figure 12. Product Picture of Paromomycin Figure 13. Product Picture of Tinidazole Figure 14. Product Picture of Other Figure 15. Global Amebiasis Market Share by Type in 2022 & 2028 Figure 16. Global Amebiasis Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Amebiasis Sales Market Share in Value by Type (2017-2028) Figure 18. Global Amebiasis Sales by Type (2017-2028) & (K MT) Figure 19. Global Amebiasis Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Amebiasis Price by Type (2017-2028) & (USD/MT) Figure 21. United States Amebiasis Market Share by Type in 2022 & 2028 Figure 22. United States Amebiasis Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Amebiasis Sales Market Share in Value by Type (2017-2028) Figure 24. United States Amebiasis Sales by Type (2017-2028) & (K MT) Figure 25. United States Amebiasis Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Amebiasis Price by Type (2017-2028) & (USD/MT) Figure 27. Product Picture of Hospital Figure 28. Product Picture of Pharmacy Figure 29. Global Amebiasis Market Share by Application in 2022 & 2028 Figure 30. Global Amebiasis Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Amebiasis Sales Market Share in Value by Application (2017-2028) Figure 32. Global Amebiasis Sales by Application (2017-2028) & (K MT) Figure 33. Global Amebiasis Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Amebiasis Price by Application (2017-2028) & (USD/MT) Figure 35. United States Amebiasis Market Share by Application in 2022 & 2028 Figure 36. United States Amebiasis Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Amebiasis Sales Market Share in Value by Application (2017-2028) Figure 38. United States Amebiasis Sales by Application (2017-2028) & (K MT) Figure 39. United States Amebiasis Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Amebiasis Price by Application (2017-2028) & (USD/MT) Figure 41. North America Amebiasis Sales in Volume Growth Rate 2017-2028 (K MT) Figure 42. North America Amebiasis Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Amebiasis Sales in Volume Growth Rate 2017-2028 (K MT) Figure 46. Europe Amebiasis Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Amebiasis Sales in Volume Growth Rate 2017-2028 (K MT) Figure 53. Asia-Pacific Amebiasis Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Amebiasis Sales in Volume Growth Rate 2017-2028 (K MT) Figure 65. Latin America Amebiasis Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Amebiasis Sales in Volume Growth Rate 2017-2028 (K MT) Figure 70. Middle East & Africa Amebiasis Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Amebiasis Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Amebiasis Value Chain Figure 75. Amebiasis Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Dr. Reddy’s Laboratories Mission Pharmacal Aceto Corporation Mylan Pharmaceuticals Impax Laboratories Pfizer Sanofi Lupin Pharmaceuticals Glenmark Pharmaceuticals Sun Pharmaceutical Heritage Pharmaceuticals